CDK2-IN-13

• CAT Number: M139371
• CAS Number: 101622-53-1
• Molecular Formula: C13H12ClN5
• Molecular Weight: 273.72
• Purity: ≥95%
• Synonyms: N-benzyl-2-chloro-9-methylpurin-6-amine
• InChI: InChI=1S/C13H12ClN5/c1-19-8-16-10-11(17-13(14)18-12(10)19)15-7-9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H,15,17,18)
• InChIKey: QNKNBVBQFILDGJ-UHFFFAOYSA-N
• SMILES: CN1C=NC2=C(N=C(N=C21)Cl)NCC3=CC=CC=C3

CDK2-IN-13 (Cat No.: M139371) is a potent and selective small molecule inhibitor of Cyclin-Dependent Kinase 2 (CDK2), a key regulator of cell cycle progression, particularly the G1 to S phase transition. By targeting CDK2 activity, CDK2-IN-13 induces cell cycle arrest and apoptosis, making it a valuable research tool in oncology and cell biology. It is used to investigate CDK2-driven tumor growth, resistance mechanisms, and potential combination therapies. CDK2-IN-13 supports the development of targeted cancer therapeutics and exploration of cell cycle control pathways.

Reference

[1]. Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12.
[Content Brief]